康泰佐利德对抗结核病的结构,特性和临床实用性:叙述性审查
Tao Chen1,2, Weili Li2, Fangxue Shen2
1Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China.
Infectious diseases and therapy
|December 2, 2025
概括
康特佐利德 (CZD) 为治疗耐药结核病 (DR-TB) 提供了一个有希望的替代方案. 这种新型的oxazolidinone药物显示出与linezolid (LZD) 相似或更好的疗效,副作用较少,有助于结核病治疗.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 结核病 (TB) 仍然是一个全球性卫生挑战,特别是在中国.
- 利尼佐利德 (LZD) 推用于耐药结核病 (DR-TB),但具有显著的不耐受性和不良事件.
- 需要新的药物来克服结核病治疗中的LZD限制.
研究的目的:
- 审查用于结核病治疗的康特佐利德 (CZD) 的开发,作用机制,耐药性和研究进展.
- 评估CZD作为抗结核治疗中LZD的潜在替代品.
- 为临床应用和对CZD的未来研究提供参考资料.
主要方法:
- 关于康泰佐利德 (CZD) 的科学出版物的文献综述.
- 关于CZD的疗效和安全性的临床前和临床研究的分析.
- 检查CZD的药理动力学特征和代谢途径.
主要成果:
- 孔特佐利德 (CZD) 的抗菌活性与线佐利德 (LZD) 的抗菌活性相当或更高.
- 与LZD相比,CZD的骨髓抑制,神经毒性和乳酸酸的风险较低.
- 良好的药理动力学和独特的代谢途径支持CZD在结核病治疗中的潜力.
结论:
- 康特佐利德 (CZD) 是对线佐利德 (LZD) 的一个有希望的替代品,用于治疗耐药结核病.
- 由于CZD的改善安全性,可能会提高结核病患者的长期坚持和治疗结果.
- 进一步的研究和CZD的临床应用是有效结核病治疗的必要条件.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
8.3K
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.8K
相关概念视频
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: